Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Centene (NYSE:CNC) with a Neutral recommendation.

Guggenheim initiated coverage of Centene (CNC) with a Neutral rating. The firm launched coverage on 11 healthcare services stocks, spanning ...

Centene (NYSE:CNC) stock trades higher as Jefferies upgrades amid Medicaid market optimism and low valuation. Read more here.

Fintel reports that on April 8, 2025, Jefferies upgraded their outlook for Centene (NYSE:CNC) from Underperform to Hold.

Jefferies upgraded Centene (CNC) to Hold from Underperform with a price target of $64, up from $53. Jefferies expects near-term multiple ...